Results 61 to 70 of about 463,075 (306)

Case Report: Multiple atherosclerotic plaques at its extreme in synchrony [version 3; peer review: 2 approved]

open access: yesF1000Research
Peripheral artery (PAD) disease in association with renal artery stenosis is an important association which predicts the severity of the disease. An increase in the number of vessels affected by peripheral artery disease increases the chances of renal ...
Gajendra Agrawal   +8 more
doaj   +1 more source

Three cases of fusion imaging in endovascular treatment of occlusive peripheral artery disease

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2019
Endovascular treatment of peripheral artery disease has dramatically improved in the past decades; however, occlusive or stenotic lesions of the femoral-popliteal artery segment remain a significant challenge for vascular specialists.
Makoto Haga, MD, PhD   +3 more
doaj   +1 more source

Prevalence of peripheral arterial diseases in patients with large artery ischemic stroke and its prognostic value

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2020
Background Peripheral artery disease (PAD) can be an important predictor of comorbid cerebrovascular disease (CVD). However, it is not sufficiently investigated or considered in the management and prevention of stroke.
Sherien Farag   +4 more
doaj   +1 more source

Peripheral Artery Disease and Stroke

open access: yesJournal of Cardiovascular Echography, 2018
Peripheral artery disease (PAD) and stroke can occur as vascular complication of anticancer treatment. Although the mechanisms, monitoring, and management of cardiotoxicities have received broad attention, vascular toxicities remain often underrecognized.
Zito, Concetta   +4 more
openaire   +3 more sources

Clinical Validation of Plasma p‐217tau in Neurological Diseases

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi   +13 more
wiley   +1 more source

Peripheral artery disease in diabetes

open access: yesFrontiers in Endocrinology
Peripheral artery disease in diabetes mellitus represents a distinct clinical entity characterized by diffuse distal arterial disease, medial calcification, microvascular dysfunction, neuropathy, and a pro-thromboinflammatory milieu.
Sheena Amin, Eri Fukaya, Anand Athavale
doaj   +1 more source

Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review

open access: yesAtherosclerosis Plus, 2021
Background and aims: The increasing prevalence of diabetes mellitus is causing a massive growth of peripheral artery disease incidences, a disabling complication of diabetic atherosclerosis, which leads often to the amputation of the affected limb ...
Federico Biscetti   +6 more
doaj   +1 more source

Five years of peripheral percutaneous transluminal angioplasty : the St Luke’s Hospital experience [PDF]

open access: yes, 1995
This article reviews the first series of 54 cases of Percutaneous Transluminal Angioplasty on the peripheral vasculature performed at the Radiological/Surgical Department at St. Luke’s Hospital, Malta, over a five year period.
Gatt, Dennis   +2 more
core  

Shared genetic contribution of type 2 diabetes and cardiovascular disease: Implications for prognosis and treatment [PDF]

open access: yes, 2018
Purpose of Review: The increased cardiovascular disease (CVD) risk in subjects with type 2 diabetes (T2D) is well established. This review collates the available evidence and assesses the shared genetic background between T2D and CVD: the causal ...
Strawbridge, Rona J.   +1 more
core   +1 more source

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy